{"id":11817,"date":"2025-09-13T10:17:15","date_gmt":"2025-09-13T07:17:15","guid":{"rendered":"https:\/\/lexcovery.com\/2025\/09\/review-of-the-eu-legislation-for-13-09-2025\/"},"modified":"2025-09-13T10:17:15","modified_gmt":"2025-09-13T07:17:15","slug":"review-of-the-eu-legislation-for-13-09-2025","status":"publish","type":"post","link":"https:\/\/lexcovery.com\/en\/2025\/09\/review-of-the-eu-legislation-for-13-09-2025\/","title":{"rendered":"Review of the EU legislation for 13\/09\/2025"},"content":{"rendered":"<h3>Commission Implementing Regulation (EU) 2025\/1882<\/h3>\n<p>  This regulation modifies the zones designated for African Swine Fever (ASF) control within several EU member states. It amends Annex I of Implementing Regulation (EU) 2023\/594, which originally set out special disease control measures. Due to recent ASF outbreaks, the regulation adjusts the boundaries of restricted zones (Zones I, II, and III) in Estonia, Latvia, Poland, Germany, Hungary, Slovakia, Italy, Czechia and Greece, Croatia, Lithuania, and Romania. The aim is to prevent further spread of the disease through revised geographical control measures, particularly impacting farmers, animal health authorities, and transport companies operating in the affected regions.<\/p>\n<h3>Commission Implementing Regulation (EU) 2025\/1846<\/h3>\n<p>  This regulation cancels the Union authorization for the biocidal product \u2018Nordkalk QL 0-0,1\u2019, initially granted to Nordkalk AB. The cancellation was requested by the company due to commercial reasons connected to the product&#8217;s discontinued production.  It also repeals the earlier Implementing Regulation (EU) 2024\/1478 that had originally authorized the product. The regulation sets deadlines for the product&#8217;s removal from the market (March 31, 2026) and the end of its usage (September 27, 2026).<\/p>\n<h3>Commission Implementing Regulation (EU) 2025\/1803<\/h3>\n<h3><strong>Review of each of legal acts published today:<\/strong><\/h3>\n<p><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/AUTO\/?uri=CELEX:32025R1882\"><\/p>\n<h3><strong>Commission Implementing Regulation (EU) 2025\/1882 of 11\u00a0September 2025 amending Annex\u00a0I to Implementing Regulation (EU)\u00a02023\/594 laying down special disease control measures for African swine fever<\/strong><\/h3>\n<p><\/a><\/p>\n<p>Okay, I will provide you with a detailed description of the provisions of this act.<\/p>\n<p>### Description of Commission Implementing Regulation (EU) 2025\/1882<\/p>\n<p>1.  **Essence of the Act**:<br \/>\n    Commission Implementing Regulation (EU) 2025\/1882 amends Annex I to Implementing Regulation (EU) 2023\/594, which lays down special disease control measures for African swine fever (ASF). This amendment updates the demarcation of restricted zones (I, II, and III) in certain Member States based on recent outbreaks of ASF. The changes aim to prevent the further spread of the disease by adjusting the geographical areas under specific control measures.<\/p>\n<p>2.  **Structure and Main Provisions**:<\/p>\n<p>    *   **Amending Act**: The regulation amends Annex I of Implementing Regulation (EU) 2023\/594.<br \/>\n    *   **Restricted Zones**: It redefines the restricted zones I, II, and III in Estonia, Latvia, Poland, Germany, Hungary, Slovakia, Italy, Czechia and Greece, Croatia, Lithuania, and Romania. These zones are categorized based on the risk level of ASF spread.<br \/>\n    *   **Specific Amendments**:<br \/>\n        *   **Estonia**: Adjustments due to new outbreaks in Viljandi county, leading to the reclassification of certain areas from restricted zone II to III.<br \/>\n        *   **Latvia**: Changes in Zemgales, R\u012bgas, and Vidzemes counties, with areas moving from restricted zone II to III due to new outbreaks.<br \/>\n        *   **Poland**: Modifications in Zachodniopomorskie and Lubelskie regions, upgrading areas from restricted zone II to III. Additionally, an area in Kujawsko-Pomorskie region is moved from restricted zone I to II following an outbreak in a wild porcine animal.<br \/>\n    *   **Justification**: The changes are based on the epidemiological situation, the overall risk level, and scientific principles for geographically defining zoning, as outlined in the Commission Notice on ASF guidelines.<br \/>\n    *   **Entry into Force**: The regulation enters into force on the day following its publication in the Official Journal of the European Union.<\/p>\n<p>3.  **Main Provisions for Use**:<\/p>\n<p>    *   **Geographical Scope**: The most critical aspect is the detailed description of the new boundaries for restricted zones I, II, and III in the affected Member States. These descriptions are provided in Annex I, which replaces the previous version.<br \/>\n    *   **Control Measures**: Depending on the zone classification, specific disease control measures apply. These measures are outlined in the original Implementing Regulation (EU) 2023\/594 and are triggered by the zone designations in Annex I.<br \/>\n    *   **Compliance**: Member States with areas listed in Annex I must implement the special disease control measures to prevent the spread of African swine fever.<br \/>\n    *   **Reference to Guidelines**: The regulation refers to the Commission Notice on ASF guidelines, indicating that these guidelines should be consulted for the implementation of control measures.<\/p>\n<p>****<\/p>\n<p>This regulation is particularly relevant for farmers, animal health authorities, and transportation companies operating in or trading with the affected regions in Estonia, Latvia, and Poland. It is essential to consult the updated Annex I to ensure compliance with the revised zoning and associated control measures.<\/p>\n<p><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/AUTO\/?uri=CELEX:32025R1846\"><\/p>\n<h3><strong>Commission Implementing Regulation (EU) 2025\/1846 of 11\u00a0September 2025 cancelling the Union authorisation for the single biocidal product Nordkalk QL 0-0,1 in accordance with Regulation (EU) No\u00a0528\/2012 of the European Parliament and of the Council and repealing Commission Implementing Regulation (EU)\u00a02024\/1478<\/strong><\/h3>\n<p><\/a><\/p>\n<p>This Commission Implementing Regulation (EU) 2025\/1846 cancels the Union authorisation for the single biocidal product \u2018Nordkalk QL 0-0,1\u2019. The cancellation was requested by the authorisation holder, Nordkalk AB, due to commercial considerations related to the discontinuation of the product&#8217;s production. The Regulation also repeals the previous Implementing Regulation (EU) 2024\/1478, which had granted the Union authorisation for the product.<\/p>\n<p>The Regulation consists of four articles.<\/p>\n<p>*   **Article 1** formally cancels the Union authorisation for \u2018Nordkalk QL 0-0,1\u2019, which was initially granted to Nordkalk AB under Implementing Regulation (EU) 2024\/1478.<br \/>\n*   **Article 2** repeals Implementing Regulation (EU) 2024\/1478, the legal act that originally authorised the biocidal product.<br \/>\n*   **Article 3** sets grace periods for the product&#8217;s market availability and use. It stipulates that \u2018Nordkalk QL 0-0,1\u2019 can no longer be made available on the market after 31 March 2026, and existing stocks must not be used after 27 September 2026.<br \/>\n*   **Article 4** specifies that the Regulation will come into force twenty days after its publication in the Official Journal of the European Union.<\/p>\n<p>The most important provision is Article 3, which defines the deadlines for the withdrawal of the biocidal product \u2018Nordkalk QL 0-0,1\u2019 from the market and the cessation of its use. This is crucial for businesses and users who need to manage their existing stocks and find alternative products.<\/p>\n<p><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/AUTO\/?uri=CELEX:32025R1803\"><\/p>\n<h3><strong>Commission Implementing Regulation (EU) 2025\/1803 of 11\u00a0September 2025 cancelling the Union authorisation for the single biocidal product Nordkalk QL 90 in accordance with Regulation (EU) No\u00a0528\/2012 of the European Parliament and of the Council and repealing Commission Implementing Regulation (EU)\u00a02024\/1672<\/strong><\/h3>\n<p><\/a><\/p>\n<p>This Commission Implementing Regulation (EU) 2025\/1803 cancels the Union authorisation for the single biocidal product \u2018Nordkalk QL 90\u2019 and repeals the previous Implementing Regulation (EU) 2024\/1672 which had granted the authorisation. The cancellation was requested by the authorisation holder, Nordkalk Oy Ab, due to commercial reasons related to the discontinuation of the product&#8217;s production. The regulation also provides a period of grace for the making available on the market and use of existing stocks of \u2018Nordkalk QL 90\u2019.<\/p>\n<p>The structure of the act is straightforward, comprising a preamble outlining the reasons for the regulation, followed by four articles.<\/p>\n<p>*   **Article 1** formally cancels the Union authorisation for \u2018Nordkalk QL 90\u2019.<br \/>\n*   **Article 2** repeals Implementing Regulation (EU) 2024\/1672, which originally granted the authorisation.<br \/>\n*   **Article 3** sets deadlines for the withdrawal of the product from the market and the cessation of the use of existing stocks.<br \/>\n*   **Article 4** specifies the date of entry into force of the regulation.<\/p>\n<p>Compared to the previous regulation (EU) 2024\/1672, this new regulation reverses the previous decision to authorise the biocidal product, effectively removing it from the Union market after the grace period.<\/p>\n<p>The most important provisions for businesses and users are found in Article 3. It states that \u2018Nordkalk QL 90\u2019 can no longer be made available on the market after 31 March 2026, and existing stocks must not be used after 27 September 2026. This provides a clear timeline for businesses to manage their inventory and for users to plan for alternative products.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Commission Implementing Regulation (EU) 2025\/1882 This regulation modifies the zones designated for African Swine Fever (ASF) control within several EU member states. It amends Annex I of Implementing Regulation (EU) 2023\/594, which originally set out special disease control measures. Due to recent ASF outbreaks, the regulation adjusts the boundaries of restricted zones (Zones I, II,&hellip;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"pmpro_default_level":"","footnotes":""},"categories":[14],"tags":[],"class_list":["post-11817","post","type-post","status-publish","format-standard","hentry","category-eu-legislation-detailed","pmpro-has-access"],"acf":{"patreon-level":0},"_links":{"self":[{"href":"https:\/\/lexcovery.com\/en\/wp-json\/wp\/v2\/posts\/11817","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lexcovery.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lexcovery.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lexcovery.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/lexcovery.com\/en\/wp-json\/wp\/v2\/comments?post=11817"}],"version-history":[{"count":0,"href":"https:\/\/lexcovery.com\/en\/wp-json\/wp\/v2\/posts\/11817\/revisions"}],"wp:attachment":[{"href":"https:\/\/lexcovery.com\/en\/wp-json\/wp\/v2\/media?parent=11817"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lexcovery.com\/en\/wp-json\/wp\/v2\/categories?post=11817"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lexcovery.com\/en\/wp-json\/wp\/v2\/tags?post=11817"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}